Obesity News

High BMI eligibility for semaglutide could cost Medicare up to $145 billion annually, a brief report published in the Annals of Internal Medicine revealed.

Adults who take semaglutide may have increased risk for developing suicidal thoughts, according to results from a case-control study published in JAMA Network Open.

A low-fat vegan diet significantly reduced harmful inflammatory dietary compounds compared with a Mediterranean diet, according to findings from a randomized study.

A majority of people with diabetes rely on their primary care provider for diabetes management and believe using drugs such as GLP-1 receptor agonists are enough to manage their disease, according to survey results.

Adults with prediabetes and overweight or obesity have a 94% lower risk for developing type 2 diabetes with the once-weekly GIP/GLP-1 dual agonist tirzepatide vs. placebo, according to top-line results from the SURMOUNT-1 3-year study.

Twelve circulating proteins associated with obesity and heart failure may inform treatment for adults with both conditions, according to a study published in Obesity.

An analysis of patients with head and neck squamous cell carcinoma who received immune checkpoint inhibitors showed those with obesity survived longer than those with normal BMI.

HU6, a controlled metabolic accelerator, met the primary endpoint of weight reduction in patients with obesity-related heart failure with preserved ejection fraction, according to top-line results of the phase 2a HuMAIN trial.

Bariatric surgery did not reduce risk for obesity-related cancer or cardiovascular disease compared with nonoperative treatment among adults aged at least 60 years, according to results of a population-based cohort study.

Maternal obesity may be linked to increased risk for sudden unexpected infant death, results from aa cohort study in JAMA Pediatrics suggest.